Skip to main content

Advertisement

SpringerLink
Log in

Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study

  • Original Article
  • Published:
Clinical Oral Investigations Aims and scope Submit manuscript

Abstract

Objectives

The aim of this study was to validate a standardized pragmatic approach to manage new oral anticoagulants (NOACs) in patients who undergo dental extractions.

Materials and methods

This prospective case-control study in patients undergoing dental extraction included 26 patients (mean age 76 years, 57% male) treated with dabigatran, rivaroxaban, or apixaban and 26 matched controls. Regardless of timing of extraction, drug regimen, or renal function, patients were instructed to skip only the dose on the morning of the procedure. A procedural bleeding score was recorded and early and delayed bleeding was assessed at day 1 and day 7. Bleeding events were compared with a prospectively matched control group not taking any antithrombotic drug.

Results

There was no difference in the procedural bleeding score or in early bleeding events (5 in both groups). However, delayed bleeding occurred more frequently in anticoagulated compared to non-anticoagulated patients (7 versus none, p = 0.01).

Conclusions

Skipping the morning dose of NOACs avoids excess bleeding during and early after the procedure. However, anticoagulated patients had an increased risk of delayed bleedings. Further study is needed to determine the optimal post-procedural management.

Clinical relevance

This is the first prospective study for the management of patients on NOACs undergoing dental extraction. Our pragmatic approach, omitting only a single morning dose, can guide clinical practice. Both patients and physicians should be aware of the increased delayed bleeding risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P, European Heart Rhythm A (2013) European Heart Rhythm Association practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 15(5):625–651. doi:10.1093/europace/eut083

    Article  PubMed  Google Scholar 

  2. Douketis JD, Spyropoulos AC, Kaatz S, Becker RC, Caprini JA, Dunn AS, Garcia DA, Jacobson A, Jaffer AK, Kong DF, Schulman S, Turpie AGG, Hasselblad V, Ortel TL (2015) Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med 373(9):823–833. doi:10.1056/NEJMoa1501035

    Article  PubMed  PubMed Central  Google Scholar 

  3. Bacci C, Maglione M, Favero L, Perini A, Di Lenarda R, Berengo M, Zanon E (2010) Management of dental extraction in patients undergoing anticoagulant treatment. Results from a large, multicentre, prospective, case-control study. Thromb Haemost 104(5):972–975. doi:10.1160/TH10-02-0139

    Article  PubMed  Google Scholar 

  4. Nematullah A, Alabousi A, Blanas N, Douketis JD, Sutherland SE (2009) Dental surgery for patients on anticoagulant therapy with warfarin: a systematic review and meta-analysis. J Can Dent Assoc 75(1):41

    PubMed  Google Scholar 

  5. Johnston S (2016) An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery. Int J Oral Maxillofac Surg 45(5):618–630. doi:10.1016/j.ijom.2015.12.010

    Article  PubMed  Google Scholar 

  6. Hanken H, Grobe A, Heiland M, Smeets R, Kluwe L, Wikner J, Koehnke R, Al-Dam A, Eichhorn W (2015) Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy. Clin Oral Investig. doi:10.1007/s00784-015-1627-9

    Google Scholar 

  7. Beyer-Westendorf J, Gelbricht V, Forster K, Ebertz F, Kohler C, Werth S, Kuhlisch E, Stange T, Thieme C, Daschkow K, Weiss N (2014) Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J 35(28):1888–1896. doi:10.1093/eurheartj/eht557

    Article  PubMed  Google Scholar 

  8. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, Committee R-LS Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151. doi:10.1056/NEJMoa0905561

    Article  PubMed  Google Scholar 

  9. Vanassche T, Hirsh J, Eikelboom JW, Ginsberg JS (2014) Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials. Thromb Haemost 112(5):918–923. doi:10.1160/th14-04-0346

    Article  PubMed  Google Scholar 

  10. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators RA (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365(10):883–891. doi:10.1056/NEJMoa1009638

    Article  PubMed  Google Scholar 

  11. Sherwood MW, Douketis JD, Patel MR, Piccini JP, Hellkamp AS, Lokhnygina Y, Spyropoulos AC, Hankey GJ, Singer DE, Nessel CC, Mahaffey KW, Fox KAA, Califf RM, Becker RC (2014) Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from ROCKET AF. Circulation. doi:10.1161/circulationaha.113.005754

    PubMed Central  Google Scholar 

  12. Iwabuchi H, Imai Y, Asanami S, Shirakawa M, Yamane GY, Ogiuchi H, Kurashina K, Miyata M, Nakao H, Imai H (2014) Evaluation of postextraction bleeding incidence to compare patients receiving and not receiving warfarin therapy: a cross-sectional, multicentre, observational study. BMJ Open 4(12):e005777. doi:10.1136/bmjopen-2014-005777

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Kapucijnenvoer 33, 3000, Leuven, Belgium

    Isabel Miclotte, Jimoh Olubanwo Agbaje, Paul Legrand & Constantinus Politis

  2. Department of Cardiovascular Medicine, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium

    Maarten Vanhaverbeke, Thomas Vanassche & Peter Verhamme

Authors
  1. Isabel Miclotte
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maarten Vanhaverbeke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jimoh Olubanwo Agbaje
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Legrand
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Thomas Vanassche
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Peter Verhamme
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Constantinus Politis
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Isabel Miclotte.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

The work was supported by the Department of Oral and Maxillofacial Surgery, University Hospitals Leuven, Belgium.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miclotte, I., Vanhaverbeke, M., Agbaje, J.O. et al. Pragmatic approach to manage new oral anticoagulants in patients undergoing dental extractions: a prospective case-control study. Clin Oral Invest 21, 2183–2188 (2017). https://doi.org/10.1007/s00784-016-2010-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00784-016-2010-1

Keywords

Search

Navigation